Journal Article10.1002/GPS.2572
Hypertension is a potential risk factor for vascular dementia: systematic review
228
TL;DR: A meta‐analysis of epidemiological and case control studies is conducted to determine whether arterial hypertension is specifically associated with an increased risk of vascular dementia (VaD).
read more
Abstract: OBJECTIVE: The aim of the study was to conduct a meta-analysis of epidemiological and case control studies to determine whether arterial hypertension is specifically associated with an increased risk of vascular dementia (VaD). DESIGN: Longitudinal and cross-sectional prospective studies using operationalised criteria to define VaD and hypertension, with a normal control comparison group were systematically reviewed. Cochrane Library, Embase, Medline, and PsycInfo data sources were searched along with reference lists of included articles and reviews. Original, prevalence or incidence studies were included if operationalised criteria for hypertension and VaD as well as number of cases with and without hypertension in VaD and non-demented groups were provided. Intervention studies and post-stroke and CADASIL studies were excluded. RESULTS: Eleven studies recruiting either volunteers or clinical patients, or which were population-based, examined a total of 768 people with VaD and 9857 control cases. A meta-analysis of the six longitudinal studies showed that hypertension was significantly associated with increased risk of incident VaD (odds ratio, OR: 1.59, CI: 1.29-1.95, p < 0.0001). A similar association between hypertension and the risk of prevalent VaD was found in the five cross-sectional studies (OR: 4.84, CI: 3.52-6.67, p < 0.00001). CONCLUSIONS: Hypertension significantly increases the risk of vascular dementia. The current meta-analysis highlights the potential importance of rigorous treatment of hypertension as a key measure to help prevent the development of VaD. Copyright © 2010 John Wiley & Sons, Ltd.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The pathobiology of vascular dementia
TL;DR: This review will examine how vascular damage disrupts vital homeostatic interactions in brain health, focusing on the hemispheric white matter, a region at heightened risk for vascular damage, and on the interplay between vascular factors and Alzheimer's disease.
1.6K
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.
TL;DR: There is sufficiently strong evidence, from a population‐based perspective, to conclude that regular physical activity and management of cardiovascular risk factors reduce the risk of cognitive decline and may reduce therisk of dementia.
1.5K
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.
TL;DR: Zhou et al. as discussed by the authors summarized the current data on the global epidemiology of blood pressure and hypertension and evaluate changes over time, and discussed interventions that can reduce the burden of high blood pressure.
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4
James E. Bennett,Gretchen A Stevens,Colin Mathers,Ruth Bonita,Jürgen Rehm,Margaret E Kruk,Leanne M. Riley,Katie Dain,Andre P Kengne,Andre P Kengne,Kalipso Chalkidou,Jessica Beagley,Sandeep P. Kishore,Wanqing Chen,Shekhar Saxena,Douglas Bettcher,John Grove,Robert Beaglehole,Majid Ezzati +18 more
TL;DR: The third UN High-Level Meeting on Non-Communicable Diseases (NCDs) on Sept 27, 2018, will review national and global progress towards the prevention and control of NCDs, and provide an opportunity to renew, reinforce, and enhance commitments to reduce their burden.
719
Post-stroke cognitive impairment: epidemiology, mechanisms and management
Jia-Hao Sun,Lan Tan,Jin-Tai Yu +2 more
TL;DR: The epidemiological features and the mechanisms of post-stroke cognitive impairment are described, the promising management strategies for these patients are discussed, and the treatments may benefit from the anti-dementia drugs, but also the manage measures on cerebrovascular diseases.
644
References
Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease.
Emel Koseoglu,Yahya Karaman +1 more
TL;DR: The increase of Hcy in AD were seemed to be not related to cerebrovascular injury, possibly related to biochemical damages as result of oxidative stress.
73
Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain)
Manuel Fernández Martínez,Jessica Castro Flores,Susana Pérez de las Heras,Aitziber Mandaluniz Lekumberri,María Gordejuela Menocal,Juan José Zarranz Imirizaldu +5 more
TL;DR: The aim of this study was to identify the risk factors for dementia, Alzheimer's disease (AD) and vascular dementia (VD) in elderly people in Munguialde County (Spain).
Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
TL;DR: To assess the effects of blood pressure lowering treatments for the prevention of dementia and cognitive decline in patients with hypertension but no history of cerebrovascular disease, trials identified through a search of the Cochrane Dementia and Cognitive Impairment Group’s Specialised Register were identified.
56
Vascular dementia among elderly Arabs in Wadi Ara.
TL;DR: The results show that VaD constitutes about 22% of the total dementia population in Wadi Ara, Israel, and confirm the association between VaD, illiteracy and hypertension.
36
Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10 000 patients and review of the literature
TL;DR: Data indicate an association with blood pressure reduction and improvement of cognitive function with eprosartan treatment, including the elderly, patients with higher initial systolic blood pressure and patients with a body mass index of 25–30 kg/m2 showed the greatest change in MMSE score.
22
Related Papers (5)
Philip B. Gorelick,Angelo Scuteri,Sandra E. Black,Charles DeCarli,Steven M. Greenberg,Costantino Iadecola,Lenore J. Launer,Stéphane Laurent,Oscar L. Lopez,David L. Nyenhuis,Ronald C. Petersen,Julie A. Schneider,Christophe Tzourio,Donna K. Arnett,David A. Bennett,Helena C. Chui,Randall T. Higashida,Ruth Lindquist,Peter M. Nilsson,Gustavo C. Román,Frank W. Sellke,Sudha Seshadri +21 more
Gustavo C. Román,Thomas K. Tatemichi,T. Erkinjuntti,Jeffrey L. Cummings,Joseph C. Masdeu,J. H. Garcia,L. Amaducci,J. M. Orgogozo,A. Brun,Albert Hofman,D. M. Moody,M. D. O’Brien,T. Yamaguchi,Jordan Grafman,B. P. Drayer,D. A. Bennett,Marc Fisher,J. Ogata,E. Kokmen,F. Bermejo,Philip A. Wolf,P. B. Gorelick,K. L. Bick,A. K. Pajeau,M. A. Bell,Charles DeCarli,A. Culebras,Amos D. Korczyn,J. Bogousslavsky,A. Hartmann,P. Scheinberg +30 more